Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder, Fritz H ; Hugosson, Jonas ; Roobol, Monique J ; Tammela, Teuvo L J ; Zappa, Marco ; Nelen, Vera ; Kwiatkowski, Maciej ; Lujan, Marcos ; Määttänen, Liisa and Lilja, Hans LU
, et al.
(2014)
In The Lancet
384(9959).
p.2027-2035
- Abstract
- The European Randomised study of Screening for Prostate Cancer (ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 years of follow-up, but screening is controversial because of adverse events such as overdiagnosis. We provide updated results of mortality from prostate cancer with follow-up to 2010, with analyses truncated at 9, 11, and 13 years.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4615008
- author
- Schröder, Fritz H
; Hugosson, Jonas
; Roobol, Monique J
; Tammela, Teuvo L J
; Zappa, Marco
; Nelen, Vera
; Kwiatkowski, Maciej
; Lujan, Marcos
; Määttänen, Liisa
and Lilja, Hans
LU
, et al. (More)
- Schröder, Fritz H
; Hugosson, Jonas
; Roobol, Monique J
; Tammela, Teuvo L J
; Zappa, Marco
; Nelen, Vera
; Kwiatkowski, Maciej
; Lujan, Marcos
; Määttänen, Liisa
; Lilja, Hans
LU
; Denis, Louis J
; Recker, Franz
; Paez, Alvaro
; Bangma, Chris H
; Carlsson, Sigrid
LU
; Puliti, Donella
; Villers, Arnauld
; Rebillard, Xavier
; Hakama, Matti
; Stenman, Ulf-Hakan
; Kujala, Paula
; Taari, Kimmo
; Aus, Gunnar
; Huber, Andreas
; van der Kwast, Theo H
; van Schaik, Ron H N
; de Koning, Harry J
; Moss, Sue M
and Auvinen, Anssi
(Less)
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The Lancet
- volume
- 384
- issue
- 9959
- pages
- 2027 - 2035
- publisher
- Elsevier
- external identifiers
-
- pmid:25108889
- wos:000346353600024
- scopus:84919871373
- ISSN
- 1474-547X
- DOI
- 10.1016/S0140-6736(14)60525-0
- language
- English
- LU publication?
- yes
- id
- 08f826e4-7e0e-489a-869a-7387e4206df7 (old id 4615008)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25108889?dopt=Abstract
- date added to LUP
- 2016-04-01 10:11:00
- date last changed
- 2023-12-21 12:05:55
@article{08f826e4-7e0e-489a-869a-7387e4206df7,
abstract = {{The European Randomised study of Screening for Prostate Cancer (ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 years of follow-up, but screening is controversial because of adverse events such as overdiagnosis. We provide updated results of mortality from prostate cancer with follow-up to 2010, with analyses truncated at 9, 11, and 13 years.}},
author = {{Schröder, Fritz H and Hugosson, Jonas and Roobol, Monique J and Tammela, Teuvo L J and Zappa, Marco and Nelen, Vera and Kwiatkowski, Maciej and Lujan, Marcos and Määttänen, Liisa and Lilja, Hans and Denis, Louis J and Recker, Franz and Paez, Alvaro and Bangma, Chris H and Carlsson, Sigrid and Puliti, Donella and Villers, Arnauld and Rebillard, Xavier and Hakama, Matti and Stenman, Ulf-Hakan and Kujala, Paula and Taari, Kimmo and Aus, Gunnar and Huber, Andreas and van der Kwast, Theo H and van Schaik, Ron H N and de Koning, Harry J and Moss, Sue M and Auvinen, Anssi}},
issn = {{1474-547X}},
language = {{eng}},
number = {{9959}},
pages = {{2027--2035}},
publisher = {{Elsevier}},
series = {{The Lancet}},
title = {{Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.}},
url = {{http://dx.doi.org/10.1016/S0140-6736(14)60525-0}},
doi = {{10.1016/S0140-6736(14)60525-0}},
volume = {{384}},
year = {{2014}},
}